{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:20:00Z","timestamp":1759159200737,"version":"3.40.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s11908-007-0062-8","type":"journal-article","created":{"date-parts":[[2007,9,10]],"date-time":"2007-09-10T09:22:42Z","timestamp":1189416162000},"page":"398-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment of community-associated methicillin-resistant Staphylococcus aureus"],"prefix":"10.1007","volume":"9","author":[{"given":"Kyle J.","family":"Popovich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bala","family":"Hota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,11]]},"reference":[{"key":"62_CR1","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa043252","volume":"352","author":"S.K. Fridkin","year":"2005","unstructured":"Fridkin SK, Hageman JC, Morrison M, et al.: Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352:1436\u20131444.","journal-title":"N Engl J Med"},{"key":"62_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1086\/511033","volume":"44","author":"L.G. Miller","year":"2007","unstructured":"Miller LG, Perdreau-Remington F, Bayer AS, et al.: Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007, 44:471\u2013482.","journal-title":"Clin Infect Dis"},{"key":"62_CR3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3201\/eid0908.030089","volume":"9","author":"F. Vandenesch","year":"2003","unstructured":"Vandenesch F, Naimi T, Enright MC, et al.: Communityacquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003, 9:978\u2013984.","journal-title":"Emerg Infect Dis"},{"key":"62_CR4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2807\/esm.09.01.00440-en","volume":"9","author":"W. Witte","year":"2004","unstructured":"Witte W, Cuny C, Strommenger B, et al.: Emergence of a new community acquired MRSA strain in Germany. Euro Surveill 2004, 9:16\u201318.","journal-title":"Euro Surveill"},{"key":"62_CR5","doi-asserted-by":"crossref","unstructured":"Larsen A, Stegger M, Goering R, et al.: Emergence and dissemination of the methicillin resistant Staphylococcus aureus USA300 clone in Denmark (2000\u20132005). Euro Surveill 2007, 12, Epub ahead of print.","DOI":"10.2807\/esm.12.02.00682-en"},{"key":"62_CR6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.10.3.505","volume":"10","author":"J. Kluytmans","year":"1997","unstructured":"Kluytmans J, van Belkum A, Verbrugh H: Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997, 10:505\u2013520.","journal-title":"Clin Microbiol Rev"},{"key":"62_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM200101043440102","volume":"344","author":"C. von Eiff","year":"2001","unstructured":"von Eiff C, Becker K, Machka K, et al.: Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001, 344:11\u201316.","journal-title":"N Engl J Med"},{"key":"62_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1086\/499632","volume":"193","author":"M.J. Kuehnert","year":"2006","unstructured":"Kuehnert MJ, Kruszon-Moran D, Hill HA, et al.: Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001\u20132002. J Infect Dis 2006, 193:172\u2013179.","journal-title":"J Infect Dis"},{"key":"62_CR9","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1086\/317484","volume":"31","author":"S. Harbarth","year":"2000","unstructured":"Harbarth S, Liassine N, Dharan S, et al.: Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2000, 31:1380\u20131385.","journal-title":"Clin Infect Dis"},{"key":"62_CR10","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1128\/AAC.43.6.1412","volume":"43","author":"S. Harbarth","year":"1999","unstructured":"Harbarth S, Dharan S, Liassine N, et al.: Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999, 43:1412\u20131416.","journal-title":"Antimicrob Agents Chemother"},{"key":"62_CR11","doi-asserted-by":"publisher","first-page":"5992","DOI":"10.1128\/JCM.43.12.5992-5995.2005","volume":"43","author":"J.M. Boyce","year":"2005","unstructured":"Boyce JM, Havill NL, Maria B: Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005, 43:5992\u20135995.","journal-title":"J Clin Microbiol"},{"key":"62_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/01.inf.0000168746.62226.a4","volume":"24","author":"C.B. Creech","year":"2005","unstructured":"Creech CB 2nd, Kernodle DS, Alsentzer A, et al.: Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 2005, 24:617\u2013621.","journal-title":"Pediatr Infect Dis J"},{"key":"62_CR13","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.1128\/AEM.69.11.6489-6494.2003","volume":"69","author":"J.H. Lee","year":"2003","unstructured":"Lee JH: Methicillin (Oxacillin)-resistant Staphylococcus aureus strains isolated from major food animals and their potential transmission to humans. Appl Environ Microbiol 2003, 69:6489\u20136494.","journal-title":"Appl Environ Microbiol"},{"key":"62_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.vetmic.2006.01.004","volume":"115","author":"J.S. Weese","year":"2006","unstructured":"Weese JS, Dick H, Willey BM, et al.: Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet Microbiol 2006, 115:148\u2013155.","journal-title":"Vet Microbiol"},{"key":"62_CR15","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1086\/423965","volume":"39","author":"M.W. Ellis","year":"2004","unstructured":"Ellis MW, Hospenthal DR, Dooley DP, et al.: Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004, 39:971\u2013979.","journal-title":"Clin Infect Dis"},{"key":"62_CR16","unstructured":"Popovich KJ, Weinstein RA, Rice T, et al.: Are communityassociated methicillin-resistant Staphylococcus aureus (CA-MRSA) strains replacing traditional nosocomial MRSA? Presented at the 17th Society for Healthcare Epidemiology of America Meeting. Baltimore; April 14\u201317, 2007."},{"key":"62_CR17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMoa042683","volume":"352","author":"L.G. Miller","year":"2005","unstructured":"Miller LG, Perdreau-Remington F, Rieg G, et al.: Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005, 352:1445\u20131453.","journal-title":"N Engl J Med"},{"key":"62_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/01.inf.0000109288.06912.21","volume":"23","author":"M.C. Lee","year":"2004","unstructured":"Lee MC, Rios AM, Aten MF, et al.: Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004, 23:123\u2013127.","journal-title":"Pediatr Infect Dis J"},{"key":"62_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1086\/511872","volume":"44","author":"J.J. Ruhe","year":"2007","unstructured":"Ruhe JJ, Smith N, Bradsher RW, Menon A: Communityonset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis 2007, 44:777\u2013784.","journal-title":"Clin Infect Dis"},{"key":"62_CR20","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1086\/511884","volume":"44","author":"R.J. Gorwitz","year":"2007","unstructured":"Gorwitz RJ: The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2007, 44:785\u2013787.","journal-title":"Clin Infect Dis"},{"key":"62_CR21","unstructured":"Gorwitz RJ, Jernigan DB, Powers JH, et al.: Strategies for clinical management of MRSA in the community: Summary of an experts\u2019 meeting convened by the Centers for Disease Control and Prevention. Available at http:\/\/www.cdc.gov\/ncidod\/dhqp\/pdf\/ar\/CAMRSA_ExpMtgStrategies.pdf. Accessed June 21, 2007."},{"key":"62_CR22","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1086\/497143","volume":"41","author":"D.L. Stevens","year":"2005","unstructured":"Stevens DL, Bisno AL, Chambers HF, et al.: Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005, 41:1373\u20131406.","journal-title":"Clin Infect Dis"},{"key":"62_CR23","doi-asserted-by":"crossref","first-page":"504","DOI":"10.7205\/MILMED.171.6.504","volume":"171","author":"E.V. Barnes","year":"2006","unstructured":"Barnes EV 2nd, Dooley DP, Hepburn MJ, Baum SE: Outcomes of community-acquired, methicillin-resistant Staphylococcus aureus, soft tissue infections treated with antibiotics other than vancomycin. Mil Med 2006, 171:504\u2013507.","journal-title":"Mil Med"},{"key":"62_CR24","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1378\/chest.128.4.2732","volume":"128","author":"S.T. Micek","year":"2005","unstructured":"Micek ST, Dunne M, Kollef MH: Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 2005, 128:2732\u20132738.","journal-title":"Chest"},{"key":"62_CR25","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1128\/JCM.00254-06","volume":"44","author":"H. Huang","year":"2006","unstructured":"Huang H, Flynn NM, King JH, et al.: Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J Clin Microbiol 2006, 44:2423\u20132427.","journal-title":"J Clin Microbiol"},{"key":"62_CR26","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1128\/JCM.02582-05","volume":"44","author":"M. Patel","year":"2006","unstructured":"Patel M, Waites KB, Moser SA, et al.: Prevalence of inducible clindamycin resistance among community-and hospital-associated Staphylococcus aureus isolates. J Clin Microbiol 2006, 44:2481\u20132484.","journal-title":"J Clin Microbiol"},{"key":"62_CR27","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1093\/jac\/dki286","volume":"56","author":"J. Tamayo","year":"2005","unstructured":"Tamayo J, Perez-Trallero E, Gomez-Garces JL, Alos JI: Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004. J Antimicrob Chemother 2005, 56:780\u2013782.","journal-title":"J Antimicrob Chemother"},{"key":"62_CR28","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1086\/429628","volume":"40","author":"J.J. Ruhe","year":"2005","unstructured":"Ruhe JJ, Monson T, Bradsher RW, Menon A: Use of longacting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis 2005, 40:1429\u20131434.","journal-title":"Clin Infect Dis"},{"key":"62_CR29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3201\/eid1103.040481","volume":"11","author":"J.S. Weese","year":"2005","unstructured":"Weese JS, Archambault M, Willey BM, et al.: Methicillinresistant Staphylococcus aureus in horses and horse personnel, 2000\u20132002. Emerg Infect Dis 2005, 11:430\u2013435.","journal-title":"Emerg Infect Dis"},{"key":"62_CR30","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/JCM.37.6.1727-1731.1999","volume":"37","author":"M.K. York","year":"1999","unstructured":"York MK, Gibbs L, Perdreau-Remington F, Brooks GF: Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California. J Clin Microbiol 1999, 37:1727\u20131731.","journal-title":"J Clin Microbiol"},{"key":"62_CR31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/mdr.2004.10.231","volume":"10","author":"H.U. Nielsen","year":"2004","unstructured":"Nielsen HU, Hammerum AM, Ekelund K, et al.: Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes? Microb Drug Resist 2004, 10:231\u2013238.","journal-title":"pyogenes? Microb Drug Resist"},{"key":"62_CR32","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1086\/314712","volume":"179","author":"V.G. Fowler Jr","year":"1999","unstructured":"Fowler VG Jr, Kong LK, Corey GR, et al.: Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis 1999, 179:1157\u20131161.","journal-title":"J Infect Dis"},{"issue":"Suppl1","key":"62_CR33","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1086\/491714","volume":"42","author":"D.L. Stevens","year":"2006","unstructured":"Stevens DL: The role of vancomycin in the treatment paradigm. Clin Infect Dis 2006, 42(Suppl 1):S51\u201357.","journal-title":"Clin Infect Dis"},{"key":"62_CR34","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1128\/JCM.01388-06","volume":"44","author":"G. Wang","year":"2006","unstructured":"Wang G, Hindler JF, Ward KW, Bruckner DA: Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol 2006, 44:3883\u20133886.","journal-title":"J Clin Microbiol"},{"key":"62_CR35","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1086\/513203","volume":"44","author":"F.C. Tenover","year":"2007","unstructured":"Tenover FC, Moellering RC Jr: The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis 2007, 44:1208\u20131215.","journal-title":"Clin Infect Dis"},{"key":"62_CR36","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","volume":"42","author":"G. Sakoulas","year":"2004","unstructured":"Sakoulas G, Moise-Broder PA, Schentag J, et al.: Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004, 42:2398\u20132402.","journal-title":"J Clin Microbiol"},{"key":"62_CR37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3201\/eid1303.060960","volume":"13","author":"C.J. Graber","year":"2007","unstructured":"Graber CJ, Wong MK, Carleton HA, et al.: Intermediate vancomycin susceptibility in a community-associated MRSA clone. Emerg Infect Dis 2007, 13:491\u2013493.","journal-title":"Emerg Infect Dis"},{"key":"62_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ijantimicag.2005.10.009","volume":"27","author":"S.L. Kleinschmidt","year":"2006","unstructured":"Kleinschmidt SL, Munckhof WJ, Nimmo GR: In vitro exposure of community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains to vancomycin: does vancomycin resistance occur? Int J Antimicrob Agents 2006, 27:168\u2013170.","journal-title":"Int J Antimicrob Agents"},{"key":"62_CR39","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","volume":"171","author":"American Thoracic Society, Infectious Diseases Society of America","year":"2005","unstructured":"American Thoracic Society, Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcareassociated pneumonia. Am J Respir Crit Care Med 2005, 171:388\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"key":"62_CR40","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","volume":"166","author":"L.K. Hidayat","year":"2006","unstructured":"Hidayat LK, Hsu DI, Quist R, et al.: High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 2006, 166:2138\u20132144.","journal-title":"Arch Intern Med"},{"key":"62_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1086\/380449","volume":"38","author":"B.A. Lipsky","year":"2004","unstructured":"Lipsky BA, Itani K, Norden C: Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam\/amoxicillinclavulanate. Clin Infect Dis 2004, 38:17\u201324.","journal-title":"Clin Infect Dis"},{"key":"62_CR42","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1086\/423841","volume":"39","author":"V.G. Meka","year":"2004","unstructured":"Meka VG, Gold HS: Antimicrobial resistance to linezolid. Clin Infect Dis 2004, 39:1010\u20131015.","journal-title":"Clin Infect Dis"},{"key":"62_CR43","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"355","author":"V.G. Fowler Jr","year":"2006","unstructured":"Fowler VG Jr, Boucher HW, Corey GR, et al.: Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006, 355:653\u2013665.","journal-title":"N Engl J Med"},{"key":"62_CR44","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1128\/JCM.44.2.655-656.2006","volume":"44","author":"D.J. Skiest","year":"2006","unstructured":"Skiest DJ: Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J Clin Microbiol 2006, 44:655\u2013656.","journal-title":"J Clin Microbiol"},{"key":"62_CR45","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1086\/504379","volume":"42","author":"S. Papadopoulos","year":"2006","unstructured":"Papadopoulos S, Ball AM, Liewer SE, et al.: Rhabdomyolysis during therapy with daptomycin. Clin Infect Dis 2006, 42:e108\u2013110.","journal-title":"Clin Infect Dis"},{"key":"62_CR46","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/163.6.1279","volume":"163","author":"H.M. Blumberg","year":"1991","unstructured":"Blumberg HM, Rimland D, Carroll DJ, et al.: Rapid development of ciprofloxacin resistance in methicillin-susceptible and-resistant Staphylococcus aureus. J Infect Dis 1991, 163:1279\u20131285.","journal-title":"J Infect Dis"},{"key":"62_CR47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1086\/646499","volume":"13","author":"L.J. Strausbaugh","year":"1992","unstructured":"Strausbaugh LJ, Jacobson C, Sewell DL, et al.: Antimicrobial therapy for methicillin-resistant Staphylococcus aureus colonization in residents and staff of a Veterans Affairs nursing home care unit. Infect Control Hosp Epidemiol 1992, 13:151\u2013159.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"62_CR48","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/01.qco.0000186850.54040.fc","volume":"18","author":"M.W. Ellis","year":"2005","unstructured":"Ellis MW, Lewis JS 2nd: Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections. Curr Opin Infect Dis 2005, 18:496\u2013501.","journal-title":"Curr Opin Infect Dis"},{"key":"62_CR49","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0149-2918(04)90070-7","volume":"26","author":"R.G. Postier","year":"2004","unstructured":"Postier RG, Green SL, Klein SR, et al.: Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients. Clin Ther 2004, 26:704\u2013714.","journal-title":"Clin Ther"},{"key":"62_CR50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.diagmicrobio.2003.09.004","volume":"48","author":"J.M. Streit","year":"2004","unstructured":"Streit JM, Fritsche TR, Sader HS, Jones RN: Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates. Diagn Microbiol Infect Dis 2004, 48:137\u2013143.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"62_CR51","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1574-6976.2003.tb00628.x","volume":"26","author":"N.E. Allen","year":"2003","unstructured":"Allen NE, Nicas TI: Mechanism of action of oritavancin and related glycopeptide antibiotics. FEMS Microbiol Rev 2003, 26:511\u2013532.","journal-title":"FEMS Microbiol Rev"},{"key":"62_CR52","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1086\/429914","volume":"40","author":"M.E. Stryjewski","year":"2005","unstructured":"Stryjewski ME, O\u2019Riordan WD, Lau WK, et al.: Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria. Clin Infect Dis 2005, 40:1601\u20131607.","journal-title":"Clin Infect Dis"},{"issue":"Suppl2","key":"62_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1469-0691.2006.01402.x","volume":"12","author":"P.C. Appelbaum","year":"2006","unstructured":"Appelbaum PC: MRSA-the tip of the iceberg. Clin Microbiol Infect 2006, 12(Suppl 2):3\u201310.","journal-title":"Clin Microbiol Infect"},{"key":"62_CR54","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1136\/bmj.324.7350.1394","volume":"324","author":"V.C. Weston","year":"2002","unstructured":"Weston VC, Boswell TC, Finch RG, Perkins W: Fusidic acid cream for impetigo. Emergence of resistance to fusidic acid limits its use. BMJ 2002, 324:1394.","journal-title":"BMJ"},{"key":"62_CR55","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2165\/00128071-200405040-00004","volume":"5","author":"I.B. Gosbell","year":"2004","unstructured":"Gosbell IB: Methicillin-resistant Staphylococcus aureus: impact on dermatology practice. Am J Clin Dermatol 2004, 5:239\u2013259.","journal-title":"Am J Clin Dermatol"},{"key":"62_CR56","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ajic.2003.12.008","volume":"32","author":"L. Halcon","year":"2004","unstructured":"Halcon L, Milkus K: Staphylococcus aureus and wounds: a review of tea tree oil as a promising antimicrobial. Am J Infect Control 2004, 32:402\u2013408.","journal-title":"Am J Infect Control"},{"key":"62_CR57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jhin.2004.01.008","volume":"56","author":"M.S. Dryden","year":"2004","unstructured":"Dryden MS, Dailly S, Crouch M: A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J Hosp Infect 2004, 56:283\u2013286.","journal-title":"J Hosp Infect"},{"key":"62_CR58","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1056\/NEJMoa064725","volume":"356","author":"D.V. Henley","year":"2007","unstructured":"Henley DV, Lipson N, Korach KS, Bloch CA: Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med 2007, 356:479\u2013485.","journal-title":"N Engl J Med"},{"key":"62_CR59","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/jac\/dkl443","volume":"59","author":"M.A. McMahon","year":"2007","unstructured":"McMahon MA, Blair IS, Moore JE, McDowell DA: Habituation to sub-lethal concentrations of tea tree oil (Melaleuca alternifolia) is associated with reduced susceptibility to antibiotics in human pathogens. J Antimicrob Chemother 2007, 59:125\u2013127.","journal-title":"J Antimicrob Chemother"},{"key":"62_CR60","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1128\/AAC.01066-06","volume":"51","author":"D.R. Gentry","year":"2007","unstructured":"Gentry DR, Rittenhouse SF, McCloskey L, Holmes DJ: Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin. Antimicrob Agents Chemother 2007, 51:2048\u20132052.","journal-title":"Antimicrob Agents Chemother"},{"key":"62_CR61","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1128\/AAC.00178-06","volume":"50","author":"S. Rittenhouse","year":"2006","unstructured":"Rittenhouse S, Biswas S, Broskey J, et al.: Selection of retapamulin, a novel pleuromutilin for topical use. Antimicrob Agents Chemother 2006, 50:3882\u20133885.","journal-title":"Antimicrob Agents Chemother"},{"key":"62_CR62","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1086\/502413","volume":"25","author":"S.H. Wootton","year":"2004","unstructured":"Wootton SH, Arnold K, Hill HA, et al.: Intervention to reduce the incidence of methicillin-resistant Staphylococcus aureus skin infections in a correctional facility in Georgia. Infect Control Hosp Epidemiol 2004, 25:402\u2013407.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"62_CR63","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1001\/jama.260.18.2682","volume":"260","author":"M.S. Klempner","year":"1988","unstructured":"Klempner MS, Styrt B: Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy. JAMA 1988, 260:2682\u20132685.","journal-title":"JAMA"},{"key":"62_CR64","first-page":"170","volume":"14","author":"M.A. Martin","year":"1994","unstructured":"Martin MA: Methicillin-resistant Staphylococcus aureus: the persistent resistant nosocomial pathogen. Curr Clin Top Infect Dis 1994, 14:170\u2013191.","journal-title":"Curr Clin Top Infect Dis"},{"key":"62_CR65","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJMoa011297","volume":"346","author":"H. Shinefield","year":"2002","unstructured":"Shinefield H, Black S, Fattom A, et al.: Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N Engl J Med 2002, 346:491\u2013496.","journal-title":"N Engl J Med"},{"key":"62_CR66","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1086\/500627","volume":"27","author":"M. Eveillard","year":"2006","unstructured":"Eveillard M, de Lassence A, Lancien E, et al.: Evaluation of a strategy of screening multiple anatomical sites for methicillin-resistant Staphylococcus aureus at admission to a teaching hospital. Infect Control Hosp Epidemiol 2006, 27:181\u2013184.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"62_CR67","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/01.inf.0000177287.11971.d4","volume":"24","author":"J.A. Rihn","year":"2005","unstructured":"Rihn JA, Posfay-Barbe K, Harner CD, et al.: Communityacquired methicillin-resistant Staphylococcus aureus outbreak in a local high school football team unsuccessful interventions. Pediatr Infect Dis J 2005, 24:841\u2013843.","journal-title":"Pediatr Infect Dis J"},{"key":"62_CR68","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1001\/archinte.156.10.1109","volume":"156","author":"R. Raz","year":"1996","unstructured":"Raz R, Miron D, Colodner R, et al.: A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. Arch Intern Med 1996, 156:1109\u20131112.","journal-title":"Arch Intern Med"},{"key":"62_CR69","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1056\/NEJMoa003069","volume":"346","author":"T.M. Perl","year":"2002","unstructured":"Perl TM, Cullen JJ, Wenzel RP, et al.: Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002, 346:1871\u20131877.","journal-title":"N Engl J Med"},{"key":"62_CR70","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1001\/archinte.154.13.1505","volume":"154","author":"B.N. Doebbeling","year":"1994","unstructured":"Doebbeling BN, Reagan DR, Pfaller MA, et al.: Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Arch Intern Med 1994, 154:1505\u20131508.","journal-title":"Arch Intern Med"},{"key":"62_CR71","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(06)68231-7","volume":"367","author":"B.A. Diep","year":"2006","unstructured":"Diep BA, Gill SR, Chang RF, et al.: Complete genome sequence of USA300, an epidemic clone of communityacquired meticillin-resistant Staphylococcus aureus. Lancet 2006, 367:731\u2013739.","journal-title":"Lancet"},{"issue":"Suppl1","key":"62_CR72","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jhin.2006.01.001","volume":"63","author":"J.E. Coia","year":"2006","unstructured":"Coia JE, Duckworth GJ, Edwards DI, et al.: Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006, 63(Suppl 1):S1\u201344.","journal-title":"J Hosp Infect"},{"key":"62_CR73","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1086\/510392","volume":"44","author":"A.E. Simor","year":"2007","unstructured":"Simor AE, Phillips E, McGeer A, et al.: Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007, 44:178\u2013185.","journal-title":"Clin Infect Dis"},{"key":"62_CR74","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1086\/500625","volume":"27","author":"A.M. Sandri","year":"2006","unstructured":"Sandri AM, Dalarosa MG, Ruschel de Alcantara L, et al.: Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 2006, 27:185\u2013187.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"62_CR75","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jaad.2004.03.010","volume":"51","author":"P.R. Cohen","year":"2004","unstructured":"Cohen PR, Grossman ME: Management of cutaneous lesions associated with an emerging epidemic: communityacquired methicillin-resistant Staphylococcus aureus skin infections. J Am Acad Dermatol 2004, 51:132\u2013135.","journal-title":"J Am Acad Dermatol"},{"key":"62_CR76","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1086\/501872","volume":"22","author":"M. Guilhermetti","year":"2001","unstructured":"Guilhermetti M, Hernandes SE, Fukushigue Y, et al.: Effectiveness of hand-cleansing agents for removing methicillin-resistant Staphylococcus aureus from contaminated hands. Infect Control Hosp Epidemiol 2001, 22:105\u2013108.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"62_CR77","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM198607103150204","volume":"315","author":"V.L. Yu","year":"1986","unstructured":"Yu VL, Goetz A, Wagener M, et al.: Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986, 315:91\u201396.","journal-title":"N Engl J Med"},{"key":"62_CR78","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0195-6701(00)90830-2","volume":"46","author":"M. Caelli","year":"2000","unstructured":"Caelli M, Porteous J, Carson CF, et al.: Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000, 46:236\u2013237.","journal-title":"J Hosp Infect"},{"key":"62_CR79","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1086\/517503","volume":"44","author":"M. Wiese-Posselt","year":"2007","unstructured":"Wiese-Posselt M, Heuck D, Draeger A, et al.: Successful termination of a furunculosis outbreak due to lukS-lukFpositive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002\u20132005. Clin Infect Dis 2007, 44:e88\u201395.","journal-title":"Clin Infect Dis"},{"key":"62_CR80","unstructured":"Dellit T, Duchin J, Hofmann J, Olson EG: Interim guidelines for evaluation and management of communityassociated methicillin-resistant staphylococcus aureus skin and soft tissue infections in outpatient setting. Available at http:\/\/www.doh.wa.gov\/Topics\/Antibiotics\/MRSAInterim.htm. Accessed June 21, 2007."},{"key":"62_CR81","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1086\/502213","volume":"24","author":"C.A. Muto","year":"2003","unstructured":"Muto CA, Jernigan JA, Ostrowsky BE, et al.: SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003, 24:362\u2013386.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"62_CR82","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1086\/647190","volume":"17","author":"J.S. Garner","year":"1996","unstructured":"Garner JS: Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996, 17:53\u201380.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"RR-16","key":"62_CR83","first-page":"1","volume":"51","author":"J.M. Boyce","year":"2002","unstructured":"Boyce JM, Pittet D: Guideline for Hand Hygiene in Health-Care Settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC\/SHEA\/APIC\/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America\/Association for Professionals in Infection Control\/Infectious Diseases Society of America. MMWR Recomm Rep 2002, 51(RR-16):1\u201345, quiz CE1-4.","journal-title":"MMWR Recomm Rep"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-007-0062-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-007-0062-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-007-0062-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-007-0062-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:30:30Z","timestamp":1744169430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-007-0062-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1007\/s11908-007-0062-8","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"type":"print","value":"1523-3847"},{"type":"electronic","value":"1534-3146"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"11 September 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}